These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2472246)
21. A systematic overview of chemotherapy effects in ovarian cancer. Högberg T; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940 [TBL] [Abstract][Full Text] [Related]
22. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow RE; Montz FJ Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412 [TBL] [Abstract][Full Text] [Related]
23. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. Gillette-Cloven N; Burger RA; Monk BJ; McMeekin DS; Vasilev S; DiSaia PJ; Kohler MF J Am Coll Surg; 2001 Dec; 193(6):626-32. PubMed ID: 11768679 [TBL] [Abstract][Full Text] [Related]
24. Secondary cytoreduction for ovarian cancer following cisplatin therapy. Segna RA; Dottino PR; Mandeli JP; Konsker K; Cohen CJ J Clin Oncol; 1993 Mar; 11(3):434-9. PubMed ID: 8445417 [TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer. Medina-Franco H; Cortés-González R; Lambreton-Hinojosa F; Fimbres-Morales A; Vargas-Siordia JC Ann Surg Oncol; 2017 May; 24(5):1330-1335. PubMed ID: 27995454 [TBL] [Abstract][Full Text] [Related]
26. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours. Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780 [TBL] [Abstract][Full Text] [Related]
27. Outcomes of patients with advanced stage ovarian cancer with intestinal metastasis. Kebapcı E; Gülseren V; Tuğmen C; Gökçü M; Solmaz U; Sert İ; Kocaer M; Özer M; Ölmez M; Sancı M Ginekol Pol; 2017; 88(10):537-542. PubMed ID: 29192414 [TBL] [Abstract][Full Text] [Related]
28. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149 [TBL] [Abstract][Full Text] [Related]
29. Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy. Morris M; Gershenson DM; Wharton JT Gynecol Oncol; 1989 Apr; 33(1):1-5. PubMed ID: 2703158 [TBL] [Abstract][Full Text] [Related]
30. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes. Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561 [TBL] [Abstract][Full Text] [Related]
31. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience. Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738 [TBL] [Abstract][Full Text] [Related]
32. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital. van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496 [TBL] [Abstract][Full Text] [Related]